🎯 check PF-02341066 (Crizotinib) product page
PF-02341066 (Crizotinib) is a potent, multi-target ATP-competitive ALK, MET, and ROS1 inhibitor. It blocks ALK/MET/ROS1 and downstream AKT/ERK/STAT3 signaling by binding to the kinase ATP-binding sites, effectively inhibiting tumor cell proliferation, migration, and inducing apoptosis.